Literature DB >> 24981406

The effect of growth hormone replacement therapy on the morphological and functional changes in the left ventricle in patients with adult-onset growth hormone deficiency.

Anton Dlesk1, Gabriel Kamenský, Ivica Lazúrová, Martin Kužma, Juraj Payer.   

Abstract

OBJECTIVE: The aim of the study was to evaluate the effect of growth hormone (GH) replacement therapy on the morphological and functional changes in the left ventricle (LV) in patients with GH deficiency (GHD).
METHODS: Patients with adult-onset GHD were treated with GH. Transthoracic echocardiography was performed at baseline and after 6 and 12 months of the treatment. Interventricular septal thickness (IVST), posterior wall thickness (PWT), left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic volume (LVEDV), left ventricular mass (LVM), stroke volume (SV) and left ventricular ejection fraction (LVEF) were evaluated at echocardiography, and the values at respective time points were compared by a paired t-test. In addition, a gender-stratified analysis was performed.
RESULTS: A total of 45 patients (21 men, 24 women; age: 19-61 years) with GHD were included. At 6 months, only increased PWT (+ 0.2 mm; P = 0.044) was significantly changed compared with baseline. At 12 months of the replacement therapy, statistically significant increase in LVM (+ 8.6 g; P = 0.035) and improvement of LVEF (+ 1.4 %; P = 0.005) were seen. In men, significantly higher values of IVST, PWT, LVEDD, LVEDV, SV and LVM were found at 12 months of follow-up, while no such effect was observed in women.
CONCLUSION: A mild increase in LVM and improvement of LVEF accompanies long-term GH replacement therapy. The effect on LV morphology is more pronounced in men than in women.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24981406     DOI: 10.1007/s00508-014-0536-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  22 in total

Review 1.  Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution.

Authors:  Albert G Burger; John P Monson; Anna M Colao; Anne Klibanski
Journal:  Endocr Pract       Date:  2006 Nov-Dec       Impact factor: 3.443

2.  Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency.

Authors:  Goo-Yeong Cho; In-Kyung Jeong; Seong Hwan Kim; Min-Kyu Kim; Woo-Jung Park; Dong-Jin Oh; Hyung-Joon Yoo
Journal:  Am J Cardiol       Date:  2007-09-15       Impact factor: 2.778

3.  Impaired cardiac performance in elderly patients with growth hormone deficiency.

Authors:  A Colao; A Cuocolo; C Di Somma; G Cerbone; A M Della Morte; E Nicolai; R Lucci; M Salvatore; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

4.  Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency.

Authors:  J C ter Maaten; H de Boer; O Kamp; L Stuurman; E A van der Veen
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

5.  Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

Authors:  G Amato; G Mazziotti; C Di Somma; E Lalli; G De Felice; M Conte; M Rotondi; M Pietrosante; G Lombardi; A Bellastella; C Carella; A Colao
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.

Authors:  A Colao; C di Somma; A Cuocolo; L Spinelli; N Tedesco; R Pivonello; D Bonaduce; M Salvatore; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

7.  Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.

Authors:  Annamaria Colao; Carolina Di Somma; Alberto Cuocolo; Letizia Spinelli; Wanda Acampa; Stefano Spiezia; Francesca Rota; Maria Cristina Savanelli; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

8.  Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.

Authors:  M Pfeifer; R Verhovec; B Zizek; J Prezelj; P Poredos; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

9.  Cardiovascular risk factors in adult patients with growth hormone deficiency.

Authors:  T Rosén; S Edén; G Larson; L Wilhelmsen; B A Bengtsson
Journal:  Acta Endocrinol (Copenh)       Date:  1993-09

10.  Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles.

Authors:  A Cittadini; Y Ishiguro; H Strömer; M Spindler; A C Moses; R Clark; P S Douglas; J S Ingwall; J P Morgan
Journal:  Circ Res       Date:  1998-07-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.